Chemogenetic Seizure Control with Clozapine and the Novel Ligand JHU37160 Outperforms the Effects of Levetiracetam in the Intrahippocampal Kainic Acid Mouse Model

2021 ◽  
Author(s):  
Jana Desloovere ◽  
Paul Boon ◽  
Lars Emil Larsen ◽  
Marie-Gabrielle Goossens ◽  
Jean Delbeke ◽  
...  
2018 ◽  
Vol 12 ◽  
Author(s):  
Gaojie Pan ◽  
Zhicai Chen ◽  
Honghua Zheng ◽  
Yunwu Zhang ◽  
Huaxi Xu ◽  
...  

Author(s):  
Eva Haas ◽  
Rana D. Incebacak ◽  
Thomas Hentrich ◽  
Chrisovalantou Huridou ◽  
Thorsten Schmidt ◽  
...  

AbstractSpinocerebellar ataxia type 3 is the most common autosomal dominant inherited ataxia worldwide, caused by a CAG repeat expansion in the Ataxin-3 gene resulting in a polyglutamine (polyQ)-expansion in the corresponding protein. The disease is characterized by neuropathological, phenotypical, and specific transcriptional changes in affected brain regions. So far, there is no mouse model available representing all the different aspects of the disease, yet highly needed for a better understanding of the disease pathomechanisms. Here, we characterized a novel Ataxin-3 knock-in mouse model, expressing a heterozygous or homozygous expansion of 304 CAACAGs in the murine Ataxin-3 locus using biochemical, behavioral, and transcriptomic approaches. We compared neuropathological, and behavioral features of the new knock-in model with the in SCA3 research mostly used YAC84Q mouse model. Further, we compared transcriptional changes found in cerebellar samples of the SCA3 knock-in mice and post-mortem human SCA3 patients. The novel knock-in mouse is characterized by the expression of a polyQ-expansion in the murine Ataxin-3 protein, leading to aggregate formation, especially in brain regions known to be vulnerable in SCA3 patients, and impairment of Purkinje cells. Along these neuropathological changes, the mice showed a reduction in body weight accompanied by gait and balance instability. Transcriptomic analysis of cerebellar tissue revealed age-dependent differential expression, enriched for genes attributed to myelinating oligodendrocytes. Comparing these changes with those found in cerebellar tissue of SCA3 patients, we discovered an overlap of differentially expressed genes pointing towards similar gene expression perturbances in several genes linked to myelin sheaths and myelinating oligodendrocytes.


2019 ◽  
Vol 15 (5) ◽  
pp. 919-928 ◽  
Author(s):  
Naijin Xu ◽  
Linglong Huang ◽  
Xiezhao Li ◽  
Masami Watanabe ◽  
Chaoming Li ◽  
...  

Cytokine ◽  
2009 ◽  
Vol 48 (1-2) ◽  
pp. 78
Author(s):  
Katherine J. Seidl ◽  
Tsung H. Lin ◽  
Martin Hegen ◽  
Elizabeth Quadros ◽  
Cheryl L. Nickerson-Nutter ◽  
...  

2018 ◽  
Author(s):  
Jie Lu ◽  
Ming-Shu Sun ◽  
Xin-Jiang Wu ◽  
Xuan Yuan ◽  
Zhen Liu ◽  
...  

AbstractHyperuricemia (HU) is a cause of gout. Clinical studies show a link between HU and cardiovascular disease. However, the role of soluble serum urate on atherosclerosis development remains elusive. We aimed to use a new HU mouse model (Uricase/Uox knockout (KO)) to further investigate the relationship between HU and atherosclerosis. Mouse model of induced carotid atherosclerosis was established in the novel spontaneous HU Uox-KO mouse and their wild type littermates (C57BL/6J background). Mice were implanted with a perivascular collar placement around the right carotid artery in combination with a western-type diet. To investigate urate-lowering treatment (ULT) effects on intima, the mice were gavaged daily from the age of 6 weeks with allopurinol. Human umbilical vein endothelial cells (HUVECs) were co-incubated with soluble urate, with and without probenecid, to study the mechanism of urate-related atherosclerosis. The Uox-KO mice had significantly elevated serum urate levels combined with higher blood urea nitrogen and serum creatinine. Western blot analysis showed enhanced levels of atherosclerosis inflammatory response proteins. However, there were no other risk indicators for the pathogenesis of atherosclerosis, including increased fasting glucose, altered lipid and atherosclerosis characterized cardiovascular and histological manifestations. In contrast, collar placement Uox-KO mice showed severe neointimal changes in histology staining consistent with increases in intimal area and increases in proliferating cell nuclear antigen (PCNA) - and F4/80-positive cells. Allopurinol reduced neointimal areas induced by the perivascular collar in hyperuricemic mice accompanied by decreased expression of PCNA- and F4/80-positive cells (P< 0.05). ULT alleviated atherosclerosis inflammatory response factors and reactive oxygen species intensities in both collar placement Uox-KO mice and urate-stimulated HUVECs. In vitro results using HUVECs showed ROS was induced by urate and ROS induction was abrogated using antioxidants. These data demonstrate that urate per se does not trigger atherosclerosis intima lesions in mice. Urate worsens carotid neointimal lesions induced by the perivascular collar and urate-lowering therapy partially abrogates the effects. The current study warrants the further human based study on the possible benefits of urate-lowering therapy in atherosclerosis patients with HU.Summary statementWe generated a carotid collar placement atherosclerosis model in the novel spontaneous HU Uox-KO mouse and demonstrate that urate plays a contributing rather than a causal role in the carotid neointimal lesions, while urate-lowering treatment may bring additional benefits in this HU mouse model.


2020 ◽  
Vol 34 (S1) ◽  
pp. 1-1
Author(s):  
Keita Shibata ◽  
Erika Yasuda ◽  
Tomoka Nishinaga ◽  
Sarara Karasawa ◽  
Tomoaki Yamaguchi ◽  
...  

2006 ◽  
Vol 14 (7S_Part_29) ◽  
pp. P1528-P1528
Author(s):  
Allal Boutajangout ◽  
Wed Abdali ◽  
Justin Sung Tae Kim ◽  
Thomas Wisniewski

Sign in / Sign up

Export Citation Format

Share Document